Agilon Health (NYSE:AGL) Trading Down 7% – Here’s Why

Shares of Agilon Health, Inc. (NYSE:AGL) traded down 7% during trading on Friday . The company traded as low as $107.42 and last traded at $107.57. Approximately 30,281 shares were traded during trading, a decline of 91% from the average daily volume of 349,972 shares. The stock had previously closed at $115.67.

Wall Street Analysts Forecast Growth

A number of brokerages recently weighed in on AGL. Citigroup reaffirmed a “neutral” rating and issued a $80.00 price target (up from $18.75) on shares of Agilon Health in a research note on Friday, May 15th. Wall Street Zen upgraded Agilon Health from a “sell” rating to a “hold” rating in a research note on Saturday, May 9th. Barclays raised Agilon Health from an “underweight” rating to an “equal weight” rating and set a $81.00 target price for the company in a report on Tuesday, May 26th. Benchmark restated a “buy” rating and issued a $95.00 target price (up from $13.00) on shares of Agilon Health in a research report on Thursday, May 21st. Finally, Robert W. Baird lifted their price target on Agilon Health from $20.00 to $35.00 and gave the stock a “neutral” rating in a research note on Thursday, May 7th. Five analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $57.10.

Agilon Health Trading Down 4.2%

The company has a current ratio of 1.04, a quick ratio of 1.04 and a debt-to-equity ratio of 0.08. The company has a fifty day moving average price of $90.82 and a two-hundred day moving average price of $43.37. The firm has a market capitalization of $1.85 billion, a price-to-earnings ratio of -5.14 and a beta of 2.98.

Agilon Health (NYSE:AGL) last posted its quarterly earnings results on Wednesday, May 6th. The company reported $1.80 EPS for the quarter, beating the consensus estimate of $1.04 by $0.76. Agilon Health had a negative return on equity of 146.03% and a negative net margin of 6.09%.The firm had revenue of $1.42 billion during the quarter, compared to analysts’ expectations of $1.38 billion. As a group, research analysts forecast that Agilon Health, Inc. will post -3.5 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of AGL. North Peak Capital Management LLC boosted its position in shares of Agilon Health by 10.8% during the 4th quarter. North Peak Capital Management LLC now owns 38,139,937 shares of the company’s stock valued at $26,267,000 after acquiring an additional 3,715,460 shares during the last quarter. Goldman Sachs Group Inc. increased its position in Agilon Health by 196.2% during the fourth quarter. Goldman Sachs Group Inc. now owns 20,055,214 shares of the company’s stock worth $13,812,000 after purchasing an additional 13,283,930 shares during the last quarter. AQR Capital Management LLC raised its stake in Agilon Health by 1,346.6% during the fourth quarter. AQR Capital Management LLC now owns 10,211,767 shares of the company’s stock worth $7,033,000 after purchasing an additional 9,505,837 shares during the period. Charles Schwab Investment Management Inc. raised its stake in Agilon Health by 30.9% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 8,019,002 shares of the company’s stock worth $5,523,000 after purchasing an additional 1,893,434 shares during the period. Finally, Geode Capital Management LLC boosted its holdings in Agilon Health by 0.5% in the 4th quarter. Geode Capital Management LLC now owns 7,177,477 shares of the company’s stock valued at $4,944,000 after purchasing an additional 35,054 shares during the last quarter.

About Agilon Health

Agilon Health (NYSE: AGL) is a healthcare company that partners with independent primary care physicians to deliver value-based care for Medicare beneficiaries. Through risk-sharing arrangements, Agilon assumes financial responsibility for patient populations, enabling physicians to focus on preventive and proactive health management. The company provides the administrative, clinical and operational infrastructure needed to support comprehensive care delivery.

Agilon’s platform encompasses data analytics, care management, patient engagement tools and population health programs.